How Analysts Feel About Amarin Corporation plc (NASDAQ:AMRN)?

Lloyd Doyle
December 8, 2017

Raymond James & accumulated 85,390 shares. BidaskClub lowered shares of Amarin from a "buy" rating to a "hold" rating in a research report on Saturday, August 5th. Varian Med Sys Inc now has $10.17 billion valuation. It has outperformed by 12.76% the S&P500. Amarin Corp Ads (NASDAQ:AMRN) has a market capitalization of $827.17 Million and most recently 263.43 Million outstanding shares have been calculated. Therefore 100% are positive.

According to 1 analysts Sears Hldgs Corp (NASDAQ:SHLD)'s price will reach at $3 during 52 weeks. State Of New Jersey Common Pension Fund D reported 0% of its portfolio in Amarin Corporation plc (NASDAQ:AMRN). The firm earned "Buy" rating on Tuesday, June 27 by H.C. Wainwright. Amarin Corp Ads (NASDAQ:AMRN) has trailing twelve month Return on Assets of -42.9%, which is key indicator of how profitable a company is relative to its total assets. Cantor Fitzgerald maintained Amarin Corporation plc (NASDAQ:AMRN) on Monday, June 26 with "Buy" rating. The stock of Amarin Corporation plc (NASDAQ:AMRN) has "Buy" rating given on Wednesday, November 1 by Cantor Fitzgerald. Jefferies maintained Amarin Corporation plc (NASDAQ:AMRN) on Monday, June 12 with "Buy" rating. JPMorgan Chase & Co. now owns 278,134 shares of the biopharmaceutical company's stock worth $1,121,000 after buying an additional 242,544 shares during the period. The rating was maintained by H.C. Wainwright on Thursday, November 2 with "Buy". Cantor Fitzgerald maintained Amarin Corporation plc (NASDAQ:AMRN) on Tuesday, August 29 with "Buy" rating.

Amarin (NASDAQ:AMRN) traded up $0.08 during midday trading on Wednesday, hitting $3.14.

5 analysts on average are expecting Amarin Corporation plc to report earnings of $-0.04 per share for the current quarter.


Institutional investors and hedge funds have recently bought and sold shares of the business. 100.78 million shares or 1.09% less from 101.89 million shares in 2017Q1 were reported. 98,441 were reported by Northern Corp. Fmr Llc has invested 0% in Amarin Corporation plc (NASDAQ:AMRN). Commonwealth Equity reported 27,216 shares or 0% of all its holdings. Ww Asset Mgmt Inc holds 0% or 16,034 shares. Its down 4.2% from 7.36 million shares, reported previously. Perkins Capital Mngmt accumulated 41,500 shares.

While having a peek at profitability ratios Amarin Corp Ads (NASDAQ:AMRN) has trailing twelve month gross margin at 74.9%, its trailing twelve month operating margin stands at -30.9% whereas its trailing twelve month net profit margin spots at -43.9%. Wms Prns Ltd Llc owns 10,000 shares. Walleye Trading Ltd Liability Corp holds 0% of its portfolio in Amarin Corporation plc (NASDAQ:AMRN) for 1,000 shares. Renaissance Tech Limited Liability stated it has 2.29M shares.

Amarin Corporation plc, a biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States. The company had revenue of $47.10 million during the quarter, compared to analysts' expectations of $45.85 million. The companyƂ's lead product is Vascepa, a prescription-only omega-3 fatty acid capsule, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. Comparatively, AMRN posted earnings of $-0.03 per share in the same quarter, a year earlier. It is also involved in developing Vascepa for the treatment of patients with high triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol levels. The company has a debt-to-equity ratio of -1.48, a current ratio of 1.63 and a quick ratio of 1.32. Amarin Corporation plc (NASDAQ:AMRN) has risen 76.19% since December 7, 2016 and is uptrending. First Tr Excnge Trd Alphadex (FNK) was reduced too.

According to sentiments of 5 analysts the mean estimates of short term price target for the company's stock is marked at $7.6. Out of rating recommendations 0 have given the stock a Buy while 0 recommend the stock as Outperform. Stock's minimum price target estimates has been figured out at $3 while the maximum price target forecast is established at $3. RBC Capital Markets maintained the shares of VAR in report on Thursday, April 27 with "Sector Perform" rating. Cantor Fitzgerald's target price would indicate a potential upside of 226.80% from the company's current price.

Other reports by Iphone Fresh

Discuss This Article

FOLLOW OUR NEWSPAPER